THE ONLY THAI PROVIDER IN THE ATMPs SANDBOX DRUG DEVELOPMENT PROGRAM

As a testament to our unparalleled standards in stem cell banking, MEDEZE has been selected as the sole private sector participant in the Advanced Therapy Medicinal Products (ATMPs) Sandbox. This prestigious initiative, in collaboration with the Ministry of Public Health, features key pilot sites at the Bangrak Medical Center in Bangkok and Vachira Phuket Hospital. The program focuses on advancing high-level medical innovations, including Stem Cell Therapy and NK Cell Immunotherapy, under rigorous international standards.
Our participation covers four primary therapeutic areas: Osteoarthritis, Anti-Aging Medicine, Degenerative Disc Disease, and Skin Rejuvenation.
This selection reflects the superior potential of MEDEZE across our Biotechnology infrastructure, High-standard Laboratories, and Specialized Expert Teams, all of which are instrumental in driving Thailand toward becoming a definitive Regional Medical Wellness Hub.
The ATMPs Sandbox aims to elevate Precision Medicine and Precision Preventive Medicine, focusing on transformative treatments for degenerative disc disease, longevity, and colorectal cancer. By pushing the boundaries of domestic ATMP development, we ensure that the Thai people have access to cutting-edge treatments, reducing reliance on imports and strengthening the nation's healthcare ecosystem for the long term.